Crossmark

Low to moderate doses of 3-methylmethcathinone (3-MMC) produce analgesic effects in healthy volunteers: a proof of principle study with a designer drug

Crossref DOI link: https://doi.org/10.1007/s00213-025-06798-8

Published Online: 2025-05-01

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ramaekers, Johannes G https://orcid.org/0000-0003-4553-376X
Reckweg, Johannes T

Mason, Natasha L

Kuypers, Kim PC

Toennes, Stefan W

Theunissen, Eef L
Funding

Funding for this research was provided by:

Human Affairs Foundation (Human Affairs Foundation)
License Information

Text and Data Mining valid from 2025-05-01

Version of Record valid from 2025-05-01
More Information

Article History

Received: 27 February 2025

Accepted: 24 April 2025

First Online: 1 May 2025

Declarations

:

: The authors declare no competing interests.

: The current study received approval from the Medical Ethics Committee of the Academic Hospital and Maastricht University. The trial was registered with the Dutch Central Committee on Research Involving Human Subjects (CCMO) under trial number NL84174.068.23 (NL-OMON53217).

Document is current

Any future updates will be listed below